Škrott Zdeněk Ph.D.

Journals

KANELLIS, D., A. ZISI, Z. ŠKROTT, B. LEMMENS, J. ESPINOZA, M. KOSAR, A. BJÖRKMAN, X. LI, S. ARAMPATZIS, J. BARTKOVA, M. ANDUJAR-SANCHEZ, O. FERNANDEZ-CAPETILLO, M. MISTRÍK, M. LINDSTROM, J. BÁRTEK
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death and Differentiation. 2023, ISSN: 1350-9047, PMID: 37142656,
BUCHTOVÁ, T., D. LUKÁČ, Z. ŠKROTT, K. CHROMÁ, J. BÁRTEK, M. MISTRÍK
Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics. International Journal of Molecular Sciences. 2023, 24(3), 2885, ISSN: 1422-0067, PMID: 36769206,  PDF.
CHROMÁ, K., Z. ŠKROTT, J. GURSKÝ, J. BACOVSKY, P. MOUDRÝ, T. BUCHTOVÁ, M. MISTRÍK, J. BÁRTEK
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment. Cell Death & Disease. 2022, 13(3), 203, ISSN: 2041-4889, PMID: 35246527,

Intellectual property

MOLECULAR COMPLEX ASSEMBLY PARTICLES COMRISING BIS-R1, R2-DITHIOCARBAMATE-METAL COMPLEX AND A LIGAND, METHOD OF PREPARATION AND USE THEREOF "DISULFIRAM II" (Mistrík)
  1. Published Application EP 18199181.1 under EP 3636285 (15.4.2020)
  2. Published Application PCT/EP2019/077222 under WO 2020/074514 (16.4.2020)
  3. Patent: AU 2019358428. Granted: 4.8.2022. Ownership: Palacky University Olomouc. Inventors: Mistrík Martin, Bártek Jiří, Škrott Zdeněk, Džubák Petr, Hajdúch Marián
  4. Patent: JP 7220932. Granted: 3.2.2023. Ownership: Palacky University Olomouc. Inventors: Mistrík Martin, Bártek Jiří, Škrott Zdeněk, Džubák Petr, Hajdúch Marián

Status: Patents pending, Available

Open positions

Project: Cellular stress in health and disease
Supervisors: Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D.
Available: 3
Intended for: Doctoral training